Home › Encyclopedia › Epithalon: Research Status and Available Data
Research / Unapproved

Epithalon: Research Status and Available Data

Molecular formulaC14H22N4O9
Molecular weight390.35 g/mol
Registered trials0
PubChem CID219042

Anyone researching epithalon will find a lot of chatter online but little regulatory substance. Here is what the available data actually shows.

Key takeaways

  • Epithalon has no FDA-approved label and is classified as an unapproved research compound.
  • It is a synthetic tetrapeptide with the molecular formula C14H22N4O9 and a molecular weight of 390.35.
  • No registered clinical trials for epithalon are currently listed.
  • No adverse event reports are available for this compound.

What epithalon is

Epithalon is a synthetic peptide made of four amino acid residues linked in a chain. Its chemical identity is catalogued under PubChem CID 219042, with the molecular formula C14H22N4O9. There is no FDA-approved drug label for epithalon, and it is not classified under any approved pharmacologic class.

Trial footprint

Public trial registries show zero registered clinical trials for epithalon. No trial samples, phases, or statuses are available to report at this time.

FAQ

Is epithalon FDA approved?
No. Epithalon has no FDA-approved label and is considered an unapproved research compound. It is not sold as an approved drug for any indication.
What is epithalon made of?
Epithalon is a synthetic tetrapeptide with the molecular formula C14H22N4O9 and a molecular weight of 390.35. Its structure is catalogued in PubChem under CID 219042.
Are there clinical trials studying epithalon?
Current registry data shows zero registered clinical trials for epithalon. This means there is no publicly listed trial activity to report on its use in humans.
Is there safety data available for epithalon?
No adverse event reports are currently available for epithalon in the data reviewed. This limits what can be said about its safety profile.
What does 'unapproved research compound' mean for epithalon?
It means epithalon has not gone through FDA review for safety or effectiveness for any use. It lacks an approved label, approved indications, or established clinical evidence in this dataset.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 219042 ClinicalTrials.gov registry search

Updated 2026-09-19